Pfizer EPS - Earnings per Share 2010-2024 | PFE

Pfizer earnings per share (EPS) for the twelve months ending December 31, 2024 was $1.41, a 281.08% increase year-over-year.

  • Pfizer EPS for the quarter ending December 31, 2024 was $0.07, a 111.86% decline year-over-year.
  • Pfizer 2024 annual EPS was $1.41, a 281.08% increase from 2023.
  • Pfizer 2023 annual EPS was $0.37, a 93.24% decline from 2022.
  • Pfizer 2022 annual EPS was $5.47, a 42.08% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Pfizer EPS - Earnings per Share 2010-2024 | PFE

  • Pfizer EPS for the quarter ending December 31, 2024 was $0.07, a 111.86% decline year-over-year.
  • Pfizer 2024 annual EPS was $1.41, a 281.08% increase from 2023.
  • Pfizer 2023 annual EPS was $0.37, a 93.24% decline from 2022.
  • Pfizer 2022 annual EPS was $5.47, a 42.08% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B